We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEGAU
351
DELISTED
Lead Edge Growth Opportunities, Ltd Units
LEGAU
$275K 0.01%
27,049
+8,320
+44% +$83.4K
NBST
352
DELISTED
Newbury Street Acquisition Corporation Common Stock
NBST
$268K 0.01%
26,762
+8,336
+45% +$82.7K
AGGRU
353
DELISTED
Agile Growth Corp Units
AGGRU
$267K 0.01%
26,559
BGSX.U
354
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
$266K 0.01%
26,598
+5,747
+28% +$57K
PFTAU
355
DELISTED
Perception Capital Corp. III Unit
PFTAU
$259K 0.01%
25,765
+16,693
+184% +$166K
NFNT
356
DELISTED
Infinite Acquisition Corp.
NFNT
$258K 0.01%
25,208
+1,563
+7% +$15.8K
LDHAU
357
DELISTED
LDH Growth Corp I Units
LDHAU
$251K 0.01%
25,713
+1,400
+6% +$14K
HERAU
358
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$244K 0.01%
24,175
LVAC
359
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
$242K 0.01%
23,660
-2,595
-10% -$26.3K
ROSS.U
360
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
$237K 0.01%
23,499
+300
+1% +$3.01K
GFGDU
361
DELISTED
The Growth for Good Acquisition Corporation Unit
GFGDU
$230K 0.01%
22,840
+20,000
+704% +$200K
JAQC
362
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
$226K 0.01%
22,826
FNVTU
363
DELISTED
Finnovate Acquisition Corp. Units
FNVTU
$226K 0.01%
22,049
+10,500
+91% +$107K
CBRGU
364
DELISTED
Chain Bridge I Units
CBRGU
$225K 0.01%
21,972
+9,968
+83% +$102K
FLD
365
Fold Holdings
FLD
$23.4M
$221K 0.01%
22,013
-37,404
-63% -$371K
HHLA.U
366
DELISTED
HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HHLA.U
$221K 0.01%
21,906
+1,000
+5% +$10K
RENEU
367
DELISTED
Cartesian Growth Corporation II Unit
RENEU
$220K 0.01%
21,541
CIIG
368
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
$214K 0.01%
20,985
+9,180
+78% +$92.3K
REVE
369
DELISTED
Alpine Acquisition Corp
REVE
$209K 0.01%
+20,081
New +$206K
SKYAU
370
DELISTED
Skydeck Acquisition Corp. Units
SKYAU
$208K 0.01%
20,716
NBSTU
371
DELISTED
Newbury Street Acquisition Corporation Units
NBSTU
$207K 0.01%
20,745
AWIN
372
DELISTED
AERWINS Technologies Inc
AWIN
$207K 0.01%
+197
New +$202K
MBAC
373
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
$203K 0.01%
20,263
-80,728
-80% -$802K
WPCA.U
374
DELISTED
Warburg Pincus Capital Corporation I-A Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCA.U
$203K 0.01%
20,139
+14,870
+282% +$148K
AHRNU
375
DELISTED
Ahren Acquisition Corp Unit
AHRNU
$199K 0.01%
+19,500
New +$198K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.